| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 123,671 | 107,288 | 96,660 | 177,992 | | Cost of Revenue | 83,563 | 70,219 | 60,826 | 122,285 | | | Gross Profit | 40,108 | 37,069 | 35,834 | 55,707 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 40,084 | 38,684 | 38,709 | 53,385 | | Non Recurring |
-
|
-
|
-
| 68,078 | | Others | 2,832 | 3,351 | 2,490 | 3,826 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,808) | (4,966) | (5,365) | (69,582) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,808) | (4,966) | (5,365) | (69,582) | | Interest Expense | 3,873 | 4,571 | 4,501 | 3,732 | | Income Before Tax | (6,681) | (9,537) | (9,866) | (73,314) | | Income Tax Expense |
-
|
-
|
-
| 13,992 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,681) | (9,537) | (9,866) | (87,306) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,681) | (9,537) | (9,866) | (87,306) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,681) | ($9,537) | ($9,866) | ($87,306) |
|
0.51% Nasdaq 
Income Statement
